Pharmacy Services | Behavioral Healthcare Executive Skip to content Skip to navigation

Pharmacy Services

Leaders call restricting methadone treatment to clinic settings outdated

July 5, 2018  |  Gary A. Enos, Contributing Editor
article

A commentary suggests that the Controlled Substances Act should be amended to allow some office-based physician practices to prescribe methadone for opioid dependence.

Raids cause larger concern for MAT prescribers

May 31, 2018  |  Julie Miller, Editor in Chief
article

Some industry observers believe certain federal actions in the past few months have simply gone too far. In recent cases, agents executed search warrants on MAT providers with no clear rationale.

Senators push for prescribing via telemedicine

February 8, 2018  |  Tom Valentino, Senior Editor
news

A bipartisan group of senators is urging the DEA to create an exemption that would allow practitioners to prescribe controlled substances for OUD treatment via telemedicine for patients in rural areas.

DEA operation flags 26 potentially rogue pharmacies

December 6, 2017  |  Tom Valentino, Senior Editor
news

An operation conducted by the DEA’s Los Angeles field division has identified 26 pharmacies in southern California, Hawaii and Nevada that are suspected of violating the Controlled Substances Act.

Idaho to allow psychologists to prescribe medications

April 11, 2017  |  Tom Valentino, Senior Editor
news

Idaho has become the fifth U.S. state to pass legislation allowing clinical psychologists to prescribe medications for the treatment of mental health disorders.

The least you need to know about buprenorphine and PDMPs

March 3, 2017  |  Julie Miller, Editor in Chief
blog

In the fragmented healthcare system, prescription drug monitoring programs might be valuable in avoiding opioid prescription fills for buprenorphine patients.

Kroger offers naloxone over the counter

January 30, 2017  |  Julie Miller, Editor in Chief
news

The Kroger Co. announced it now offers naloxone nasal spray 4mg over the counter at its 101 pharmacies in the Dallas region.

Drug distributor settles monitoring dispute

January 18, 2017  |  Julie Miller, Editor in Chief
news

McKesson Corporation finalized a $150 million settlement to resolve claims that the company did not adequately monitor and report suspicious orders for controlled substances.

Opioid crisis declared public health emergency in Virginia

November 22, 2016  |  Tom Valentino, Senior Editor
news

With overdose cases on the rise, the Virginia state health commissioner has declared the opioid addiction crisis to be a public health emergency and issued a standing order that allows all Virginians to obtain naloxone over the counter.

How to add MAT services to your organization

November 14, 2016  |  Brian Albright
article

Deciding to add a medical dimension like MAT to an existing program is one thing; actually making the transition is another. The process involves overcoming a number of hurdles that could potentially derail the program.

Higher caps may not increase buprenorphine utilization

November 14, 2016  |  Brian Albright
article

Research from the RAND Corporation indicates that few physicians currently prescribing buprenorphine have approached the 100-patient treatment cap, and many of those might be underutilizing the drug.

Fentanyl, carfentanil prompt higher naloxone dosage

October 21, 2016  |  Tom Valentino, Senior Editor
article

Two expert panels have voted to recommend that the FDA increase the minimum dosage of naloxone in the wake of climbing overdose rates involving fentanyl and carfentanil.

Pages

Subscribe to Pharmacy Services